Countries in search of the next technology platform that will drive innovation are eyeing biotechnology—Canada included. It’s time to stop discussing whether or not to embrace biotechnology. Canada should act quickly in order to capitalize on it.
Biotechnology in Canada: A Technology Platform for Growth
Biotechnology in Canada: A Technology Platform for Growth
Canadian Economic Analysis
Sustainable Economy
$0.00
Biotechnology is a critical technology platform essential to Canada’s ongoing prosperity. Countries like Australia, the United Kingdom, India, the United States and Japan are investing heavily in research and development, aggressively developing and attracting world-class talent, and establishing highly focused strategies to harness the promises of biotechnology. In order to stay competitive in this environment, Canada needs to address several weaknesses without delay: we need to make biotechnology a strategic priority; we need to improve our commercialization track record; we need to attract more risk capital; and we need a more ample supply of highly skilled people. Biotechnology in Canada: A Technology Platform for Growth discusses why biotechnology matters, examining it through the lens of innovation to assess Canada’s past and potential performance. It explores the key issues affecting biotechnology in Canada, such as research funding, access to capital and the biotechnology workforce, in order to identify problems and suggest solutions.
Customers Who Downloaded This Also Liked
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
